FATE vs. BAC
FATE (Fate Therapeutics, Inc.) and BAC (Bank of America Corporation) are both stocks. FATE operates in Biotechnology (Healthcare), while BAC operates in Banks - Diversified (Financial Services). Over the past 10 years, FATE returned 1.80%/yr vs 18.54%/yr for BAC. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
FATE vs. BAC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FATE achieves a 149.34% return, which is significantly higher than BAC's 13.86% return. Over the past 10 years, FATE has underperformed BAC with an annualized return of 1.80%, while BAC has yielded a comparatively higher 18.54% annualized return.
FATE
- 1D
- -2.39%
- 1M
- -16.10%
- 6M
- 105.88%
- YTD
- 149.34%
- 1Y
- 128.97%
- 3Y*
- -14.86%
- 5Y*
- -50.54%
- 10Y*
- 1.80%
- ALL TIME*
- -7.39%
BAC
- 1D
- 0.36%
- 1M
- 5.48%
- 6M
- 17.71%
- YTD
- 13.86%
- 1Y
- 38.63%
- 3Y*
- 28.30%
- 5Y*
- 12.79%
- 10Y*
- 18.54%
- ALL TIME*
- 8.33%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $2.02B | $2.04B | $2.03B | |
| $3.39M | $7.02M | $9.69M |
FATE vs. BAC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FATE Fate Therapeutics, Inc. | 149.34% | -40.45% | -55.88% | -62.93% | -82.76% | -35.65% | 364.64% | 52.53% | 109.98% | 143.43% |
BAC Bank of America Corporation | 13.86% | 28.04% | 33.85% | 4.83% | -23.82% | 49.61% | -11.63% | 46.19% | -15.00% | 35.69% |
Correlation
The correlation between FATE and BAC is 0.15, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.15 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.28 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.25 |
Correlation (All Time) Calculated using the full available price history since Oct 1, 2013 | 0.23 |
The correlation between FATE and BAC shifts across timeframes, from 0.15 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
FATE:
$285.57M
BAC:
$439.63B
FATE:
-$1.09
BAC:
$4.50
FATE:
46.27
BAC:
2.61
FATE:
1.64
BAC:
1.64
FATE:
$6.32M
BAC:
$177.58B
FATE:
-$7.88M
BAC:
$115.79B
FATE:
-$135.03M
BAC:
$45.64B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FATE vs. BAC — Risk / Return Rank
FATE
BAC
FATE vs. BAC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fate Therapeutics, Inc. (FATE) and Bank of America Corporation (BAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FATE | BAC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.27 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.97 | 1.90 | +1.07 |
| Martin ratioReturn relative to average drawdown | 5.17 | 5.00 | +0.17 |
Loading charts...
Drawdowns
FATE vs. BAC - Drawdown Comparison
The maximum FATE drawdown since its inception was -99.42%, which is greater than BAC's maximum drawdown of -93.10%. Use the drawdown chart below to compare losses from any high point for FATE and BAC.
Loading charts...
Drawdown Indicators
| FATE | BAC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.42% | -93.10% | -6.32% |
Max Drawdown (1Y)Largest decline over 1 year | -41.58% | -17.93% | -23.65% |
Max Drawdown (3Y)Largest decline over 3 years | -91.86% | -27.51% | -64.35% |
Max Drawdown (5Y)Largest decline over 5 years | -99.29% | -46.64% | -52.65% |
Max Drawdown (10Y)Largest decline over 10 years | -99.42% | -48.95% | -50.47% |
Current DrawdownCurrent decline from peak | -97.91% | -1.07% | -96.84% |
Average DrawdownAverage peak-to-trough decline | -58.96% | -28.21% | -30.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.83% | 6.82% | +17.01% |
Volatility
FATE vs. BAC - Volatility Comparison
Fate Therapeutics, Inc. (FATE) has a higher volatility of 18.26% compared to Bank of America Corporation (BAC) at 5.89%. This indicates that FATE's price experiences larger fluctuations and is considered to be riskier than BAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FATE | BAC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.26% | 5.89% | +12.37% |
Volatility (6M)Calculated over the trailing 6-month period | 71.86% | 16.31% | +55.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 97.73% | 21.85% | +75.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.20% | 26.67% | +67.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.69% | 30.46% | +56.23% |
Dividends
FATE vs. BAC - Dividend Comparison
FATE has not paid dividends to shareholders, while BAC's dividend yield for the trailing twelve months is around 1.81%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAC Bank of America Corporation | 1.81% | 1.96% | 2.28% | 2.73% | 2.60% | 1.75% | 2.38% | 1.87% | 2.19% | 1.32% | 1.13% | 1.19% |
FATE Fate Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
FATE vs. BAC - Financials Comparison
This section allows you to compare key financial metrics between Fate Therapeutics, Inc. and Bank of America Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
FATE and BAC have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FATE has higher volatility (18.26%) compared to BAC (5.89%). In terms of maximum drawdown, FATE dropped -99.42% vs BAC's -93.10%.
BAC currently has the higher Sharpe Ratio (1.56 vs 1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FATE and BAC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer